Inicio › Leucemia mielógena aguda › Wisconsin

Ensayos clínicos de Leucemia mielógena aguda en Wisconsin

26 estudios sobre Leucemia mielógena aguda buscan participantes en Wisconsin.

Ciudades en Wisconsin

Texto oficial del estudio (inglés)

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

ThedaCare Regional Cancer Center, Appleton
Duluth Clinic Ashland, Ashland
Saint Vincent Hospital Cancer Center Green Bay, Green Bay
y 11 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06317649

Allogeneic iNKT Cell Therapy (agenT-797) After SCT

University of Wisconsin - Madison, Madison

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07758218

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

University of Wisconsin, Madison
Froedtert & Medical College of Wisconsin, Milwaukee

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07007312

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

ThedaCare Regional Cancer Center, Appleton
ThedaCare Regional Medical Center - Appleton, Appleton
Duluth Clinic Ashland, Ashland
y 8 más

ReclutandoFase 2

Edades de 18 a 59 · Todos los sexos · Actualizado el 9 nov 2026 · NCT05554406

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Gundersen Lutheran Medical Center, La Crosse
Medical College of Wisconsin, Milwaukee

ReclutandoFase 2

Edades de 60 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT07437950

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
ThedaCare Regional Cancer Center, Appleton
ThedaCare Regional Medical Center - Appleton, Appleton
y 50 más

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

ThedaCare Regional Cancer Center, Appleton
Duluth Clinic Ashland, Ashland
Aurora Cancer Care-Southern Lakes VLCC, Burlington
y 41 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT05564390

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Children's Hospital of Wisconsin, Milwaukee

ReclutandoEstudio observacional

Edades de 0 a 38 · Todos los sexos · Actualizado el 29 oct 2026 · NCT06131801

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

ThedaCare Regional Cancer Center, Appleton
ThedaCare Regional Medical Center - Appleton, Appleton
Duluth Clinic Ashland, Ashland
y 6 más

ReclutandoFase 2

Edades de 18 a 59 · Todos los sexos · Actualizado el 28 oct 2026 · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Duluth Clinic Ashland, Ashland
Saint Vincent Hospital Cancer Center Green Bay, Green Bay
Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay
y 9 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 27 oct 2026 · NCT06672146

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

University of Wisconsin Carbone Cancer Center, Madison

ReclutandoFase 1

7 Months – 21 Years · Todos los sexos · Actualizado el 27 oct 2026 · NCT02508038

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Froedtert & Medical College of Wisconsin, Milwaukee

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 oct 2026 · NCT04256317

Ivosidenib as Post-HSCT Maintenance for AML

Froedtert Hospital & the Medical College of Wisconsin, Milwaukee

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06707493

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Saint Vincent Hospital Cancer Center Green Bay, Green Bay
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Marshfield Medical Center-Marshfield, Marshfield
y 1 más

ReclutandoFase 3

6 Months – 21 Years · Todos los sexos · Actualizado el 17 sept 2026 · NCT04293562

A Study of BGB-11417 in Participants With Myeloid Malignancies

Medical College of Wisconsin, Milwaukee

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT04771130

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Saint Vincent Hospital Cancer Center Green Bay, Green Bay
University of Wisconsin Carbone Cancer Center - University Hospital, Madison

ReclutandoFase 3

Edades de 1 a 25 · Todos los sexos · Actualizado el 4 sept 2026 · NCT07022678

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Marshfield Medical Center-Marshfield, Marshfield

ReclutandoFase 1/2

Hasta los 22 · Todos los sexos · Actualizado el 25 ago 2026 · NCT04726241

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Froedtert & Medical College Clinics, Milwaukee

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT06001788

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

Medical College of Wisconsin, Milwaukee

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT06656494

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

University of Wisconsin - Madison, Madison
Children's Hospital of Wisconsin, Milwaukee

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 6 jul 2026 · NCT01351545

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

University of Wisconsin Carbone Cancer Center, Madison

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 may 2026 · NCT06222580

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

University of Wisconsin Carbone Cancer Center, Madison

ReclutandoFase 1

Hasta los 21 · Todos los sexos · Actualizado el 22 abr 2026 · NCT05101551

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

University of Wisconsin Hospital and Clinics, Madison
Medical College of Wisconsin Cancer Center, Milwaukee

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 mar 2026 · NCT05735184

Venetoclax to Augment Epigenetic Modification and Chemotherapy

Children's Wisconsin, Milwaukee

ReclutandoFase 1

Edades de 1 a 25 · Todos los sexos · Actualizado el 12 ene 2026 · NCT05317403

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

University of Wisconsin Clinical Science Center, Madison

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2025 · NCT06501196

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

University of Wisconsin, Madison

ReclutandoSe aceptan voluntarios sanos

Edades de 18 a 120 · Todos los sexos · Actualizado el 25 jul 2025 · NCT05237258

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.